Loading...
Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!
- Ticker
- GYRE
- Price
- 8.07
- Stock movement down
- -0.18 (-2.33%)
- Company name
- Gyre Therapeutics Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Markkapitalisasie
- 685.74M
- Ondernemingswaarde
- -
- Prys/Verkope
- -
- Prys/Boek
- -
- Dividendopbrengs
- -
- Dividendgroei
- -
- Groei jare
- -
- FCF uitbetaling
- -
- Agterlopende P/E
- -
- Volgende P/E
- 27.45
- PEG
- -
- EPS groei
- -
- 1 jaar opbrengs
- -35.80%
- 3 jaar opbrengs
- -35.66%
- 5 jaar opbrengs
- -37.60%
- 10 jaar opbrengs
- -46.36%
Laaste opgedateer: 2025-09-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDE
GYRE betaal nie dividende nie of geen data is ontvang nie
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
WAARDERING
Waarderingsverhoudings
Loading...
Waarderingsverhoudings gegewens
| Agterlopende P/E | - |
| Prys tot OCF | - |
| Prys tot FCF | - |
| Prys tot EBITDA | - |
| EV tot EBITDA | - |
Waardering (Verkope/Boekwaarde)
Loading...
Waardering (Verkope/Boekwaarde) gegewens
| Prys tot verkope | - |
| Prys tot Boekwaarde | - |
| EV tot verkope | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANSIËLE
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
AANDELE INLIGTING
Aandele grafiek
Loading...
Aandele prys data
| Open | 7.75 |
| Daaglikse hoog | 7.75 |
| Daaglikse laag | 7.47 |
| Daaglikse volume | 42K |
| Hoogtepunt van alle tye | 47155.50 |
| 1j analiseraaming | 19.00 |
| Beta | - |
| EPS (TTM) | - |
| Dividend per aandeel | - |
| Ex-dividend datum | 13 Jan 2023 |
| Volgende verdienste datum | 12 Nov 2025 |
Afwaartse potensiaal
Loading...
Afwaartse potensiaal gegewens
| GYRE | S&P500 | |
| Huidige prysdaling vanaf die hoogste punt van alle tye | -99.98% | -1.46% |
| Hoogste prysdaling | -99.99% | -56.47% |
| Datum van hoogste daling | 28 Mar 2023 | 9 Mar 2009 |
| Gemiddelde daling vanaf hoogtepunt | -75.35% | -10.99% |
| Gemiddelde tyd tot nuwe hoogtepunt | 84 days | 12 days |
| Maksimum tyd tot nuwe hoogtepunt | 3640 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
MAATSKAPPY BESONDERHEDE
Markkapitalisasie
685.74M
Markkapitalisasie kategorie
Small-cap
Beskrywing
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. The company was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.
Werknemers
579
Webwerf
Beleggerverhoudings
-
SEC lêers
CEO
Land
USA
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Seeking AlphaPersvrystellings
iO Charts is a Seeking Alpha partner